Sucheta Dalal :AstraZenca\'s \'game of delisting\' and Elliott Group finally under SEBI lens!
Sucheta Dalal

Click here for FREE MEMBERSHIP to Moneylife Foundation which entitles you to:
• Access to information on investment issues

• Invitations to attend free workshops on financial literacy
• Grievance redressal

 

 MoneyLife
You are here: Home » What's New » AstraZenca\'s \'game of delisting\' and Elliott Group finally under SEBI lens!
                       Previous           Next

AstraZenca\'s \'game of delisting\' and Elliott Group finally under SEBI lens!  

June 25, 2014

The de-listing process of pharma major AstraZeneca and the role of Elliott group has come under market regulator SEBI’s lens for violation of its regulations on fraudulent and unfair trade practices

 

Moneylife Digital Team

 

Market regulator Securities and Exchange Board of India (SEBI) has asked Bombay stock exchange (BSE) and National Stock Exchange (NSE) to keep an eye on the delisting process of AstraZeneca Pharma India Ltd (AZ India).

 

To read more on this click here


-- Sucheta Dalal